Cargando…

TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake

RATIONALE: TEAD (TEA domain transcription factor) 1—a major effector of the Hippo signaling pathway—acts as an oncoprotein in a variety of tumors. However, the function of TEAD1 in vascular smooth muscle cells (VSMCs) remains unclear. OBJECTIVE: To assess the role of TEAD1 in vascular injury–induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osman, Islam, He, Xiangqin, Liu, Jinhua, Dong, Kunzhe, Wen, Tong, Zhang, Fanzhi, Yu, Luyi, Hu, Guoqing, Xin, Hongbo, Zhang, Wei, Zhou, Jiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Molecular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493685/ https://www.ncbi.nlm.nih.gov/pubmed/30801233 http://dx.doi.org/10.1161/CIRCRESAHA.118.314187

Ejemplares similares

SLC1A5 provides glutamine and asparagine necessary for bone development in mice
por: Sharma, Deepika, et al.
Publicado: (2021)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
por: Luo, Meiying, et al.
Publicado: (2018)

Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis
por: Yuan, Zhuhui, et al.
Publicado: (2022)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Tead1 is required for perinatal cardiomyocyte proliferation
por: Liu, Ruya, et al.
Publicado: (2019)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
por: Liu, Yang, et al.
Publicado: (2022)

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
por: Guo, Chuansheng, et al.
Publicado: (2023)

TEAD1 Silencing Regulates Cell Proliferation and Resistance to 5-Fluorouracil in Cutaneous Squamous Cell Carcinoma
por: Wang, Ziyang, et al.
Publicado: (2022)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer
por: Huang, Renhong, et al.
Publicado: (2023)

A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells
por: Venkateswaran, Geetha, et al.
Publicado: (2023)

Cooperative binding of AP-1 and TEAD4 modulates the balance between vascular smooth muscle and hemogenic cell fate
por: Obier, Nadine, et al.
Publicado: (2016)

High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
por: Liu, Yidong, et al.
Publicado: (2015)

The Glutamine Transporter Slc38a1 Regulates GABAergic Neurotransmission and Synaptic Plasticity
por: Qureshi, Tayyaba, et al.
Publicado: (2019)

The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well
por: Scalise, Mariafrancesca, et al.
Publicado: (2020)

YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation
por: Zheng, Jian-Pu, et al.
Publicado: (2020)

Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration
por: Brosch, Philippa K., et al.
Publicado: (2022)

SLC1A3 facilitates Newcastle disease virus replication by regulating glutamine catabolism
por: Liu, Panrao, et al.
Publicado: (2022)

SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
por: Xiong, Jie, et al.
Publicado: (2021)

The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1)
por: He, Songlin, et al.
Publicado: (2021)

Independent variant analysis of TEAD1 and OCEL1 in 38 Aicardi syndrome patients
por: Wong, Bibiana K. Y., et al.
Publicado: (2017)

Genomic analysis of circular RNAs in heart
por: Dong, Kunzhe, et al.
Publicado: (2020)

Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283
por: Lin, Ye, et al.
Publicado: (2020)

A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
por: Tajan, Mylène, et al.
Publicado: (2018)

Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis
por: Qureshi, Tayyaba, et al.
Publicado: (2020)

Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family
por: Freidman, Natasha J., et al.
Publicado: (2022)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential
por: Wang, Renjie, et al.
Publicado: (2020)

Circ_0000463 contributes to the progression and glutamine metabolism of non‐small‐cell lung cancer by targeting miR‐924/SLC1A5 signaling
por: Liu, Yunzhong, et al.
Publicado: (2021)

SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long‐lived Myc hypomorphic mice
por: Zhao, Xiaoai, et al.
Publicado: (2019)

Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction]
Publicado: (2023)

YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2
por: Li, Jinglin, et al.
Publicado: (2022)

Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis
por: Cai, Yong, et al.
Publicado: (2022)

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27(Kip1)
por: Wang, Chunyan, et al.
Publicado: (2015)

The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients
por: Xia, Haiyan, et al.
Publicado: (2017)

TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
por: Elster, Dana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fq43tcka27nbsc8bnjn2jie00h